Get the Stockscreener App
2.945
3.33%
0.095
Tela Bio Inc stock is traded at $2.945, with a volume of 148.57K.
It is up +3.33% in the last 24 hours and up +9.07% over the past month.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
See More
Previous Close:
$2.85
Open:
$2.82
24h Volume:
148.57K
Relative Volume:
0.64
Market Cap:
$114.21M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-1.3089
EPS:
-2.25
Net Cash Flow:
$-44.47M
1W Performance:
+2.61%
1M Performance:
+9.07%
6M Performance:
-37.61%
1Y Performance:
-49.40%
1-Day Range:
$2.82
$2.96
1-Week Range:
$2.715
$2.96
52-Week Range:
$2.30
$7.84
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
Tela Bio Inc Stock (TELA) Latest News
TELA Bio Announces Inducement Grants of Restricted Stock Units to New Employees - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio (TELA) to Release Quarterly Earnings on Thursday - MarketBeat
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio - MSN
Stonepine Capital Management, LLC Increases Stake in TELA Bio Inc - GuruFocus.com
TELA Bio, Inc. Discloses Preliminary Financial Results for the Third Quarter - Defense World
Insiders Of TELA Bio Reap Rewards After Their Investment Jumps Another US$69k - Simply Wall St
Antony Koblish Bought 42% More Shares In TELA Bio - Yahoo Finance
OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc - Yahoo Finance
Tela Bio's chief technology officer buys $49,999 in stock By Investing.com - Investing.com Canada
Insider Buying: CTO Paul Talmo Acquires 22,222 Shares of TELA Bi - GuruFocus.com
Tela Bio's chief commercial officer Gregory Firestone buys $14,998 in stock - Investing.com
Tela bio COO and CFO Roberto Cuca acquires $144,999 in stock - Investing.com
Insider Purchase: Chief Commercial Officer Gregory Firestone Acq - GuruFocus.com
Insider Buying Alert: CFO Roberto Cuca Acquires Shares of TELA B - GuruFocus.com
TELA Bio, Inc. (NASDAQ:TELA) Insider Purchases $14,998.50 in Stock - MarketBeat
Tela Bio's chief technology officer buys $49,999 in stock - Investing.com
TELA Bio's SWOT analysis: innovative medtech firm faces growth hurdles - Investing.com India
Tela Bio CEO Antony Koblish purchases $199,998 in stock - Investing.com
TELA Bio Announces Closing of Public Offering of Common - GlobeNewswire
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - StockTitan
TELA Bio's SWOT analysis: innovative medtech firm faces growth hurdles By Investing.com - Investing.com South Africa
Tela Bio expects to raise $40M this week from stock and warrant sale - The Business Journals
SEC Form 424B5 filed by TELA Bio Inc. - Quantisnow
TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail
Canadian Dollar/Norwegian Krone (CADNOK) QuotePress Release - The Globe and Mail
Cfa Franc/U.S. Dollar (XOFUSD) QuotePress Release - The Globe and Mail
Piper Sandler maintains Overweight rating on TELA Bio shares - Investing.com
Piper Sandler maintains Overweight rating on TELA Bio shares By Investing.com - Investing.com UK
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
TELA Bio announces public offering of stock and warrants By Investing.com - Investing.com Australia
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
TELA Bio announces public offering of stock and warrants - Investing.com
TELA Bio Reports Q3 2024 Preliminary Financial Results - TipRanks
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
TSX Preferred Share Index (TXPR) QuotePress Release - The Globe and Mail
Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail
Dream Office REIT (D-UN-T) QuotePress Release - The Globe and Mail
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
TSX Information Tech Capped Index (TTTK) QuotePress Release - The Globe and Mail
Carmax Inc (KMX-N) QuotePress Release - The Globe and Mail
Moderna Inc (MRNA-Q) QuotePress Release - The Globe and Mail
Get Ready: TELA Bio to Unveil Q3 2024 Financial Results on November 7! - MSN
Telefonica S.A. ADR (TEF-N) QuotePress Release - The Globe and Mail
PHLX Oil Service (OSX) QuotePress Release - The Globe and Mail
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
TELA Bio to Announce Third Quarter 2024 Financial Results - GlobeNewswire
Royal Bank of Canada (RY-N) QuotePress Release - The Globe and Mail
Aware Sets Third Quarter 2024 Webcast for Wednesday, October 30, 2024, at 5:00 p.m. Eastern Time - The Manila Times
TSX 60 Equal Weight Index (TXEW) QuotePress Release - The Globe and Mail
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tela Bio Inc Stock (TELA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
| Firestone Gregory A. | Chief Business Officer |
Dec 05 '23 |
Buy |
5.65 |
2,600 |
14,688 |
35,511 |
| Cuca Roberto | COO and CFO |
Nov 14 '23 |
Buy |
4.49 |
10,000 |
44,938 |
62,371 |
| KOBLISH ANTONY | Chief Executive Officer |
Nov 14 '23 |
Buy |
4.54 |
11,000 |
49,976 |
303,634 |
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):